A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

Eli Lilly's oral pill, orforglipron, helped maintain weight loss in patients switching from injectable versions of GLP-1 ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week as it targets a fast-growing ...

Novo Nordisk said on Friday the European Medicines Agency's committee had issued a positive opinion for a higher dose of its ...

Novo Nordisk launched Ozempic in India on Friday—and the weight-loss drug will sell at a massive discount there, compared ...

Indian health-tech startup Healthify is in talks to partner with more weight-loss drugmakers to offer health, nutrition and ...

Novo Nordisk said on Thursday it filed a marketing application to the U.S. Food and Drug Administration for CagriSema, its once-weekly next-generation weight-loss drug.

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

Novo Nordisk cuts Wegovy price to $349 for cash payers early Novo launches $199 deal for Wegovy, Ozempic lowest doses GoodRx will launch a weight-loss telehealth service for $39 a month Nov 17 ...

Denmark on Thursday sharply raised its economic growth forecast for 2025, due in part to the pharmaceuticals industry, which ...

Dec 2 (Reuters) - Wegovy maker Novo Nordisk (NOVOb.CO), opens new tab is planning to test its experimental obesity drug, CagriSema, in overweight children and adolescents, according to a U.S. registry ...

Nov 24 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials testing whether the medicine can ...